Trials / Completed
CompletedNCT05757726
Early Feasibility of the Velocity™ Percutaneous PAVF System
Feasibility Study of the Velocity™ Percutaneous Arterio-Venous Fistula System
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- Venova Medical · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
An early feasibility study of the the initial safety and efficacy of the Velocity Percutaneous Arterio-Venous Fistula (pAVF) System when used to percutaneously create an arteriovenous fistula in patients with ESRD requiring hemodialysis vascular access.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Velocity pAVF system | A second generation percutaneous AVF device that creates an AVF between the proximal radial artery and cubital perforating vein. |
Timeline
- Start date
- 2023-02-14
- Primary completion
- 2023-11-15
- Completion
- 2024-10-08
- First posted
- 2023-03-07
- Last updated
- 2025-03-19
Locations
1 site across 1 country: Paraguay
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05757726. Inclusion in this directory is not an endorsement.